BioMarin Pharmaceutical Inc. (BMRN)’s Financial Results Comparing With Intec Pharma Ltd. (NASDAQ:NTEC)

As Biotechnology businesses, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and Intec Pharma Ltd. (NASDAQ:NTEC), are affected by compare. This especially applies to their analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership.

Earnings and Valuation

Table 1 highlights BioMarin Pharmaceutical Inc. and Intec Pharma Ltd.’s gross revenue, earnings per share (EPS) and valuation.

Profitability

Table 2 provides us BioMarin Pharmaceutical Inc. and Intec Pharma Ltd.?s return on equity, return on assets and net margins.

Analyst Ratings

The table given features the ratings and recommendations for BioMarin Pharmaceutical Inc. and Intec Pharma Ltd.

The upside potential is 17.51% for BioMarin Pharmaceutical Inc. with consensus target price of $111.82.

Insider Institutional Ownership

Institutional investors held 0% of BioMarin Pharmaceutical Inc. shares and 39.64% of Intec Pharma Ltd. shares. Insiders held 0.4% of BioMarin Pharmaceutical Inc. shares. Insiders Comparatively, held

... read more at: https://moveefy.com/2019/03/13/biomarin-pharmaceutical-inc-bmrns-financial-results-comparing-with-intec-pharma-ltd-nasdaqntec/

by

Leave a Reply